CARMEL, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies ...
A phase Ib trial on the safety and feasibility of low-dose radiotherapy combined with immunochemotherapy for colorectal cancer with liver-limited metastasis (TRIUNITE-04). This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results